comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 11:46:42 - browse：93

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Medical school prerequisites are outdated

WSS

In venture capital firm's success, lessons for turning crisis into profit

First transplant of an entire human eye performed

Carbon Health diabetes program, a test of data

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Medical school prerequisites are outdated

NIH chief: government has fallen behind pharma on clinical trials

Wikipedia

comprehensive

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Medicare details structure of new drug price negotiation program

Astronauts get first look at the spacecraft that will fly them around the moon

As demand for Covid shots wanes, Moderna seeks its next success

Today's health inequities arise from racist U.S. history, say experts

Anesthesiologist group: stop taking Ozempic before surgery

Weight loss drugs should be covered by insurers, AMA says

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Today's health inequities arise from racist U.S. history, say experts

explore

Experimental asthma app from Apple and Anthem shows promise

More regulation could be coming for drug ads

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Type 2 diabetes prevention programs work at large scale: study

Publishing genetic code of viruses could cause disaster

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

hotspot

entertainment

knowledge

knowledge